Docket

36918

Teva Canada Limited v. TD Canada Trust, et al.

(Ontario) (Civil) (By Leave)

Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.

Proceedings
Date Proceeding Filed By
(if applicable)
2018-04-04 Appeal closed
2018-03-09 Discontinuance of the bill of costs Teva Canada Limited
2018-02-26 Bill of costs, (Letter Form), Completed on: 2018-02-26 Teva Canada Limited
2018-01-16 Order on motion to amend, (sent by fax to all parties via fax)
2018-01-16 Decision on motion to amend, Abe Mo Ka Ga Br, UPON APPLICATION by the respondents to amend the judgment in the above appeal and to remand issues back to the Court of Appeal;
AND THE MATERIAL FILED having been read;
IT IS HEREBY ORDERED THAT:
The motion is dismissed without costs.
Dismissed, without costs
2018-01-16 Submission of motion to amend, Abe Mo Ka Ga Br
2017-12-04 Correspondence received from, (Letter Form), Nadia Effendi (in person). Explanation of the corrections to the reply. TD Canada Trust
2017-12-01 Reply to motion to amend, (Book Form), CORRECTED version filed on 2017-12-04., Completed on: 2017-12-01 TD Canada Trust
2017-11-24 Response to motion to amend, (Book Form), Completed on: 2017-11-24 Teva Canada Limited
2017-11-14 Motion to amend, (Book Form), the Court's judgment of October 27, 2017., Completed on: 2017-11-14 TD Canada Trust
2017-10-30 Formal judgment sent to the registrar of the court of appeal and all parties
2017-10-30 Judgment on appeal and notice of deposit of judgment sent to all parties
2017-10-27 Judgment on the appeal rendered, CJ Abe Mo Ka Wa Ga Côt Br Row, The appeal from the judgment of the Court of Appeal for Ontario, Number C58546, 2016 ONCA 94, dated February 2, 2016, heard on February 24, 2017, is allowed with costs and the decision of Whitaker J. is restored. McLachlin C.J. and Wagner, Côté and Rowe JJ. dissent.
Allowed, with costs
2017-03-07 Transcript received, 92 pages
2017-02-24 Judgment reserved OR rendered with reasons to follow
2017-02-24 Intervener's condensed book, (Book Form), Submitted in Court (14 copies) Canadian Generic Pharmaceutical Association
2017-02-24 Respondent's condensed book, (Book Form), Joint- Submitted in Court (14 copies) TD Canada Trust
2017-02-24 Appellant's condensed book, (Book Form), Submitted in Court (14 copies) Teva Canada Limited
2017-02-24 Hearing of the appeal, 2017-02-24, CJ Abe Mo Ka Wa Ga Côt Br Row
Judgment reserved
2017-02-22 Supplemental document, (2 copies), Completed on: 2017-02-22 TD Canada Trust
2017-02-14 Notice of appearance, Irwin Liebman and Moe Liebman will be present at the hearing. Canadian Generic Pharmaceutical Association
2017-02-10 Appeal perfected for hearing
2017-02-10 Notice of appearance, Martin Sclisizzi, Caitlin Sainsbury and Heather Pessione will be present at the hearing. Bank of Nova Scotia
2017-02-10 Correspondence received from, 4 reserved seats requested Bank of Nova Scotia
2017-02-10 Correspondence received from, 3 reserved seats requested TD Canada Trust
2017-02-10 Notice of appearance, Frank McLaughlin, Paul Steep and Shanique Lake will be present at the hearing. TD Canada Trust
2017-02-10 Certificate of counsel (attesting to record) TD Canada Trust
2017-02-10 Respondent's book of authorities, (Book Form), Joint (2 copies), Completed on: 2017-02-10 TD Canada Trust
2017-02-10 Respondent's record, (Book Form), Joint (2 copies), Completed on: 2017-02-10 TD Canada Trust
2017-02-10 Respondent's factum, (Book Form), Joint, Completed on: 2017-02-10 TD Canada Trust
2017-02-09 Intervener's book of authorities, (Book Form), Completed on: 2017-02-09 Canadian Generic Pharmaceutical Association
2017-02-09 Intervener's factum, (Book Form), Completed on: 2017-02-09 Canadian Generic Pharmaceutical Association
2017-02-03 Correspondence received from, 3 reserved seats requested Teva Canada Limited
2017-02-03 Notice of appearance, Daniel Baum, Fred Tayar and Colby Linthwaite will be present at the hearing. Mr. Linthwaite will present oral arguments. Teva Canada Limited
2017-01-20 Correspondence received from, 4 reserved seats requested Teva Canada Limited
2017-01-13 Order on motion for leave to intervene, BY JUSTICE BROWN
2017-01-13 Decision on the motion for leave to intervene, Br, UPON APPLICATION by the Canadian Generic Pharmaceutical Association for leave to intervene in the above appeal;
AND THE MATERIAL FILED having been read;
IT IS HEREBY ORDERED THAT:
The motion for leave to intervene is granted and the said intervener shall be entitled to serve and file a factum not to exceed ten (10) pages in length on or before February 10, 2017.
The said intervener is granted permission to present oral argument not exceeding five (5) minutes at the hearing of the appeal.
The intervener is not entitled to raise new issues or to adduce further evidence or otherwise to supplement the record of the parties.
Pursuant to Rule 59(1)(a) of the Rules of the Supreme Court of Canada, the intervener shall pay to the appellant and the respondents any additional disbursements occasioned to the appellant and respondents by its intervention.
Granted
2017-01-13 Submission of motion for leave to intervene, Br
2017-01-09 Response to the motion for leave to intervene, (Letter Form), Completed on: 2017-01-09, (Electronic version filed on 2017-01-09) TD Canada Trust
2016-12-28 Response to the motion for leave to intervene, (Letter Form), Completed on: 2016-12-28, (Electronic version filed on 2016-12-28) Teva Canada Limited
2016-12-22 Motion for leave to intervene, (Book Form), Completed on: 2016-12-22, (Electronic version filed on 2016-12-22) Canadian Generic Pharmaceutical Association
2016-12-12 Correspondence received from, (Letter Form), Andrew Harrison (by email). Update on contact information for counsel. Bank of Nova Scotia
2016-12-05 Certificate of counsel (attesting to record) Teva Canada Limited
2016-12-05 Appellant's book of authorities, (Book Form), Completed on: 2016-12-05 Teva Canada Limited
2016-12-05 Appellant's record, (Book Form), (3 volumes), Completed on: 2016-12-05 Teva Canada Limited
2016-12-05 Appellant's factum, (Book Form), Completed on: 2016-12-05 Teva Canada Limited
2016-11-23 Notice of hearing sent to parties
2016-11-16 Appeal hearing scheduled, 2017-02-24
Judgment reserved
2016-09-19 Notice of appeal, (Letter Form), Completed on: 2016-09-19, (Electronic version filed on 2016-09-19) Teva Canada Limited
2016-09-08 Order by, BY CHIEF JUSTICE, CJ, IT IS HEREBY ORDERED THAT:
1.Any person wishing to intervene in this appeal under Rule 55 of the Rules of the Supreme Court of Canada shall serve and file a motion for leave to intervene on or before January 3, 2017.
2.The appellant and respondents shall serve and file their responses, if any, to the motions for leave to intervene on or before January 10, 2017.
3.Replies to any responses to the motions for leave to intervene shall be served and filed on or before January 12, 2017.
4.Any interveners granted leave to intervene under Rule 59 of the Rules of the Supreme Court of Canada shall serve and file their factum and book of authorities on or before February 10, 2017.
Granted
2016-09-01 Letter advising the parties of tentative hearing date and filing deadlines (Leave granted)
2016-08-19 Copy of formal judgment sent to Registrar of the Court of Appeal and all parties
2016-08-19 Judgment on leave sent to the parties
2016-08-18 Judgment of the Court on the application for leave to appeal, The application for leave to appeal from the judgment of the Court of Appeal for Ontario, Number C58546, 2016 ONCA 94, dated February 2, 2016, is granted with costs in the cause.
Granted, with costs in the cause
2016-07-11 All materials on application for leave submitted to the Judges, CJ Mo Ga
2016-05-04 Certificate (on limitations to public access) TD Canada Trust
2016-05-04 Respondent's response on the application for leave to appeal, Joint, Completed on: 2016-05-04 TD Canada Trust
2016-04-04 Letter acknowledging receipt of a complete application for leave to appeal, File opened on 2016-04-04
2016-04-01 Certificate (on limitations to public access) Teva Canada Limited
2016-04-01 Notice of name Teva Canada Limited
2016-04-01 Application for leave to appeal, Completed on: 2016-04-01 Teva Canada Limited